Suppr超能文献

在显性和隐性橄榄体脑桥小脑萎缩中血小板谷氨酸脱氢酶活性异常及激活

Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy.

作者信息

Sorbi S, Tonini S, Giannini E, Piacentini S, Marini P, Amaducci L

出版信息

Ann Neurol. 1986 Mar;19(3):239-45. doi: 10.1002/ana.410190304.

Abstract

Glutamate dehydrogenase (GDH) activity and its allosteric modulation by purine nucleotides were studied in platelet preparations from 4 patients with a nondominant form of adult-onset olivopontocerebellar atrophy (OPCA) and in affected and nonaffected members of two families with a dominant form of OPCA. A partial deficiency of GDH activity (40 to 50% of control values) was present in 3 patients with nondominant OPCA and in 2 patients, father and son, with a dominant form of OPCA. Platelet GDH from these patients and controls was regularly inactivated by 2 mM guanosine-5'-triphosphate (GTP) and simulated one- to twofold by 2 mM adenosine-5'-diphosphate (ADP). In the presence of 0.2% Triton X-100, the activating effect of ADP was enhanced four- to sixfold. The partial deficiency in maximum catalytic activity observed in these patients persisted under all conditions used for enzyme assay. In affected members, but not in one unaffected member of another family with a dominant type of OPCA, GDH activity was in the control range but was not activated by ADP in either the presence or absence of Triton. These results suggest that there may be at least two possible alterations of GDH in patients with OPCA: one which decreases the maximum catalytic activity and one which impairs the regulatory properties of the enzyme. Furthermore, this study suggests that platelet GDH determination in patients with OPCA may provide a simple and useful tool to classify these disorders and to understand the basic pathophysiological mechanisms involved.

摘要

对4例非显性成年起病型橄榄体脑桥小脑萎缩(OPCA)患者以及两个显性OPCA家族中患病和未患病成员的血小板制剂中的谷氨酸脱氢酶(GDH)活性及其受嘌呤核苷酸的变构调节进行了研究。3例非显性OPCA患者以及2例显性OPCA患者(父子)存在GDH活性部分缺乏(为对照值的40%至50%)。这些患者和对照的血小板GDH通常会被2 mM鸟苷-5'-三磷酸(GTP)灭活,并被2 mM腺苷-5'-二磷酸(ADP)模拟激活1至2倍。在存在0.2% Triton X-100的情况下,ADP的激活作用增强了4至6倍。在用于酶测定的所有条件下,这些患者中观察到的最大催化活性部分缺乏均持续存在。在显性OPCA家族的患病成员中,但在另一个家族的一名未患病成员中,GDH活性在对照范围内,但无论是否存在Triton,均未被ADP激活。这些结果表明,OPCA患者的GDH可能至少存在两种可能的改变:一种降低最大催化活性,另一种损害酶的调节特性。此外,这项研究表明,测定OPCA患者的血小板GDH可能为分类这些疾病以及理解其中涉及的基本病理生理机制提供一种简单且有用的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验